- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02432352
Our Family Our Future: Acceptability and Feasibility Study of a Family Prevention Program for HIV Risk and Depression
Our Family Our Future: Family Prevention of HIV Risk and Depression in HIV-endemic South Africa
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Our Family Our Future Program is a preventive intervention program designed to prevent or reduce adolescent sexual risk behavior and to increase mental health resilience against depression onset among adolescents (13-15 years of age). The intervention takes a family approach and addresses HIV risk and depression in an integrated model. HIV and depression are the leading causes of global burden of disease in low and middle income countries. The intervention is being tested in South Africa, the country confronting the largest HIV epidemic in the world and because preliminary studies with South African families identified poor mental health and sexual risk behavior as priority areas for preventive intervention development and testing.
This study is a randomized pilot design, where 152 adolescents and parents will be randomly assigned to an intervention condition or a standard usual care condition and then offered the experimental intervention as on a wait-list. Families will be recruited and screened for eligibility based on systematic house-to-house recruitment in the community. Eligibility is based on dyadic eligibility and includes age criteria, consistent presence in the household, depressive symptoms that fall below clinically significant threshold criteria, and ability to provide informed consent and assent. Eligible families will be randomized and offered a preventive intervention program in a group format, led by program facilitators in a community setting. The intervention program consists of 3 sessions plus an individualized family meeting. In some modules parents/guardians/caregivers and adolescents will have content delivered together and in some modules parents/guardians/caregivers and adolescents will break out to adult-only or adolescent-only groups.
The overall objective of study is to assess the following study questions:
Question 1: Is this study feasible? Question 2: Is this intervention acceptable to the target population? Question 3: Is there preliminary evidence of hypothesized effects of the intervention, that the intervention will reduce or maintaining symptoms that fall below the clinically significant range for depression and reduce or delay actual or intended sexual risk behavior in adolescents?
The study takes a single blind, randomized pilot trial. The study takes a secondary prevention approach. The investigators collect three sets of data. First, the investigators assess feasibility by examining recruitment rates, attendance, completion, and drop-out rates, and fidelity. Second, the investigators assess acceptability by examining satisfaction data. Third, as a secondary aim, the investigators use pilot data to assess hypothesized intervention effects by examining outcomes at baseline, immediately post-intervention (2-4 weeks after the last intervention session is completed), and at four months.
Study Type
Enrollment (Anticipated)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Western Cape
-
Cape Town, Western Cape, South Africa, 780
- Caroline Kuo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
PARENTS/GUARDIANS/CAREGIVERS
- 18+ years
- primary caregiver or the person responsible for childcare in the household on a day to day basis (as identified by the household);
- when more than one primary caregiver exists in the household, one will be chosen at random;
- lives in the household at least 4 days a week
- sub clinical thresholds of depressive symptoms
Adolescent inclusion criteria are:
- 13-15 years;
- concurs that the adult identified is their primary caregiver;
- when more than one child in the family falls within the eligible age range, one child will be chosen at random;
- lives in the household at least 4 days a week;
- sub clinical thresholds of depressive symptoms
Exclusion Criteria:
PARENTS/GUARDIANS/CAREGIVERS & Adolescents
- cognitive impairments that would not allow them to provide informed consent or assent;
- if they participated in qualitative phases of the study
- report no or low symptoms or clinically significant thresholds of depression -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Families are randomly allocated to a behavioral intervention arm (called Our Family Our Future) focusing on reducing sexual risk behavior in adolescents and reducing or maintaining symptoms that fall below the clinically significant range for depression.
Arms will be allocated using urn randomization.
|
The Our Family Our Future Program is a family preventive intervention that uses resilience and prevention focused strategies to reduce sexual risk behaviors and build mental wellbeing among adolescents.
|
No Intervention: Control
Families are randomly allocated to the control arm (which receives standard usual care, and then offered the intervention after outcome assessments as a wait-list) using urn randomization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in sexual behavior or intended sexual behavior at 4 months post-intervention
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
as measured through lifetime and past 3 month sexual acts, condom use, HIV and STI status, prior pregnancy
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change or maintenance of depressive symptoms at sub-clinical range from baseline to 4 months post-intervention measured by CES-D and CES-DC
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Self-reported depressive symptoms
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Intervention acceptability - satisfaction with intervention content, delivery, length using the client satisfaction questionnaire and as measured on a likert scale response and as open-ended response options
Time Frame: acceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
|
acceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
|
|
Intervention feasibility measured by attendance, retention for outcome assessments, fidelity
Time Frame: cceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
|
cceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in resilience from baseline to 4 months post-intervention as measured through CD-RISC
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in depression impairment from baseline to 4 months post-intervention as measured through DISP and CPODMV
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in perceived HIV risk susceptibility from baseline to 4 months post-intervention using a ranking derived from a 0-100 and as measured on a likert scale response
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in HIV knowledge from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in HIV stigma from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in norms and attitudes about sex from baseline to 4 months post-intervention as measured on a likert scale response
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in norms and attitudes about condoms from baseline to 4 months post-intervention as measured through the condom attitudes scale and likert response questions
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in sexual behavior self-efficacy from baseline to 4 months post-interventionusing a ranking derived from a 0-100 and as measured on a likert scale response
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in anxiety from baseline to 4 months post-interventionas measured through BAI and RCMAS
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in psychological distress from baseline to 4 months post-intervention as measured through K6 and SDQ
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in trauma symptoms from baseline to 4 months post-intervention as measured through PCL and NSESSS
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in substance use from baseline to 4 months post-intervention as measured through AUDIT and DUDIT
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in hope from baseline to 4 months post-intervention as measured through BHS
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in social support from baseline to 4 months post-intervention as measured through MSPSS
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in family relationship from baseline to 4 months post-intervention as measured through Family Relationship Scale
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Communication Scale
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Sex Communication Scale
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in family relationship from baseline to 4 months post-intervention as measured through the Inventory of Parent-peer Attachment
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in parenting from baseline to 4 months post-interventionas measured through the Parental Monitoring Questionnaire
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Change in parenting from baseline to 4 months post-intervention as measured through the Parenting Scale
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Kuo C, Atujuna M, Mathews C, Stein DJ, Hoare J, Beardslee W, Operario D, Cluver L, K Brown L. Developing family interventions for adolescent HIV prevention in South Africa. AIDS Care. 2016;28 Suppl 1(sup1):106-10. doi: 10.1080/09540121.2016.1146396. Epub 2016 Feb 26.
- Kuo C, LoVette A, Stein DJ, Cluver LD, Brown LK, Atujuna M, Gladstone TRG, Martin J, Beardslee W. Building resilient families: Developing family interventions for preventing adolescent depression and HIV in low resource settings. Transcult Psychiatry. 2019 Feb;56(1):187-212. doi: 10.1177/1363461518799510. Epub 2018 Oct 5.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K01MH096646 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Our Family Our Future
-
Brown UniversityRhode Island Hospital; University of Cape Town; Medical Research Council, South... and other collaboratorsActive, not recruitingDepression | Sexually Transmitted Diseases | Human Immunodeficiency VirusSouth Africa
-
State University of New York - Downstate Medical...National Institute of Mental Health (NIMH); Yale UniversityEnrolling by invitationHIV I InfectionUnited States
-
National Taiwan University HospitalCompletedAutism Spectrum DisorderTaiwan
-
University of PennsylvaniaCompletedHospitalismUnited States
-
Memorial Sloan Kettering Cancer CenterNYS DEPT HEALTH CANCER SVC PROCompletedAll CancersUnited States
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
Northwell HealthPatient-Centered Outcomes Research Institute; Baylor College of Medicine; Children... and other collaboratorsRecruitingIntellectual DisabilityUnited States
-
Second Affiliated Hospital, School of Medicine,...Ningbo Medical Center Lihuili Hospital; Second Affiliated Hospital of Wenzhou... and other collaboratorsRecruitingValvular Heart DiseaseChina
-
Boston Medical CenterAetna, Inc.Completed
-
State University of New York - Upstate Medical...National Institute of Mental Health (NIMH)CompletedVelocardiofacial SyndromeUnited States